Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Kivu Bioscience Inc.
Hoffmann-La Roche
Aveni Foundation
Bayer
University of California, Irvine
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
University of Florida
Essen Biotech
MacroGenics
Avacta Life Sciences Ltd
Institut Curie
Solve Therapeutics
University of Nebraska
Adela, Inc
Perspective Therapeutics
Ocellaris Pharma, Inc.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)